FAMRX | ONGAX | FAMRX / ONGAX | |
Total Expense Ratio | 0.65 | 0.97 | 67% |
Annual Report Gross Expense Ratio | 0.65 | 1.00 | 65% |
Fund Existence | 26 years | 29 years | - |
Gain YTD | 13.205 | 10.895 | 121% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 0 | 500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.94B | 6.27B | 79% |
Annual Yield % from dividends | 1.31 | 2.15 | 61% |
Returns for 1 year | 13.27 | 12.69 | 105% |
Returns for 3 years | 33.33 | 27.38 | 122% |
Returns for 5 years | 51.85 | 42.67 | 122% |
Returns for 10 years | 88.88 | 59.55 | 149% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TADGX | 83.68 | N/A | N/A |
T. Rowe Price Dividend Growth Advisor | |||
WFDSX | 32.67 | N/A | N/A |
Allspring SMID Cap Growth Fund - Cl Inst | |||
ICTEX | 16.82 | N/A | N/A |
ICON Health and Information Tech Instl | |||
GEMUX | 27.40 | N/A | N/A |
Goldman Sachs Emerging Markets Eq R6 | |||
MLNAX | 27.06 | N/A | N/A |
Morgan Stanley Instl Glbl Concntr A |